NZ719369A - Conjugates of cell binding molecules with cytotoxic agents - Google Patents

Conjugates of cell binding molecules with cytotoxic agents Download PDF

Info

Publication number
NZ719369A
NZ719369A NZ719369A NZ71936912A NZ719369A NZ 719369 A NZ719369 A NZ 719369A NZ 719369 A NZ719369 A NZ 719369A NZ 71936912 A NZ71936912 A NZ 71936912A NZ 719369 A NZ719369 A NZ 719369A
Authority
NZ
New Zealand
Prior art keywords
conjugates
binding molecules
cytotoxic agents
cell binding
conjugate
Prior art date
Application number
NZ719369A
Other versions
NZ719369B2 (en
Inventor
R Yongxin Zhao
Yue Zhang
Yourang Ma
Original Assignee
Hangzhou Dac Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Dac Biotech Co Ltd filed Critical Hangzhou Dac Biotech Co Ltd
Priority to NZ719369A priority Critical patent/NZ719369B2/en
Priority claimed from NZ719369A external-priority patent/NZ719369B2/en
Publication of NZ719369A publication Critical patent/NZ719369A/en
Publication of NZ719369B2 publication Critical patent/NZ719369B2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A conjugate of a cytotoxic agent with a cell-surface receptor binding molecule having a structure of Formula (I) as defined in claim 1. The conjugate is used for targeted treatment of cancer, autoimmune disease, and infectious disease.
NZ719369A 2012-07-12 Conjugates of Cell Binding Molecules with Cytotoxic Agents NZ719369B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ719369A NZ719369B2 (en) 2012-07-12 Conjugates of Cell Binding Molecules with Cytotoxic Agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ719369A NZ719369B2 (en) 2012-07-12 Conjugates of Cell Binding Molecules with Cytotoxic Agents
NZ70348712 2012-07-12

Publications (2)

Publication Number Publication Date
NZ719369A true NZ719369A (en) 2017-04-28
NZ719369B2 NZ719369B2 (en) 2017-08-01

Family

ID=

Similar Documents

Publication Publication Date Title
PH12019502278A1 (en) Conjugation of a cytotoxic drug with bis-linkage
NZ717003A (en) Novel cytotoxic agents for conjugation of drugs to cell binding molecule
TR201900176T4 (en) Anti-TROP2 antibody-drug conjugate.
BR112014026730A2 (en) dr5 drug-binder conjugates
NZ710746A (en) Pyrrolobenzodiazepines and conjugates thereof
MX350539B (en) Enediyne compounds, conjugates thereof, and uses and methods therefor.
UA111341C2 (en) Conjugates of amatoxin with improved linkers
CL2007001648A1 (en) Leptomycin derived compound; conjugate comprising cell binding agent bound to one or more of said derivatives; pharmaceutical compositions comprising said derivative or conjugate; useful in the treatment of cancer; process of preparing a compound or a conjugate of a leptomycin derivative.
EA032986B1 (en) Pyrrolobenzodiazepines
PH12015500940A1 (en) Bruton`s tyrosine kinase inhibitors
NZ712035A (en) Pyrrolobenzodiazepines and conjugates thereof
NZ588884A (en) Cross-linkers and their uses
MY170719A (en) Antibody-drug conjugates
BR112014013526A2 (en) antibody-drug conjugates and related compounds, compositions and methods
EA201791843A3 (en) METHODS OF INCREASING THE EFFICIENCY OF FOLR1 CANCER THERAPY
NZ708171A (en) Oligonucleotide conjugates
MX340090B (en) Spliceostatin analogs.
MY151245A (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
MX343337B (en) Methods of preparation of conjugates.
NZ704490A (en) Glycoconjugation processes and compositions
MX2014009219A (en) Purinone compounds as kinase inhibitors.
MX2012010448A (en) Carbohydrate-polyamino acid-drug conjugates.
MX2012000575A (en) ε-POLYLYSINE CONJUGATES AND USE THEREOF.
WO2013067199A3 (en) Subcutaneous delivery of polymer conjugates of therapeutic agents
WO2013181597A3 (en) Thiol-ene click chemistry for drug conjugates

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE OWNER HAS BEEN CORRECTED TO 3172013, HANGZHOU DAC BIOTECH CO., LTD, ROOM B2001-B2019, BUILDING 2.NO. 452 SIXTH STREET, HEDA,HANGZHOU CITY, ZHEJIANG PROVINCE, 310018, CN

Effective date: 20170328

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2019 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS

Effective date: 20190106

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2020 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS

Effective date: 20190707

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2021 BY CPA GLOBAL

Effective date: 20200529

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2022 BY CPA GLOBAL

Effective date: 20210527

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2023 BY CPA GLOBAL

Effective date: 20220526

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 JUL 2024 BY CPA GLOBAL

Effective date: 20230525